p16INK4Aand p14ARFGene Promoter Hypermethylation as Prognostic Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma: A Review
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by Hindawi Limited in Disease Markers
- Vol. 2014, 1-8
Abstract
Head and neck squamous cell carcinoma is a heterogeneous group of tumors with each subtype having a distinct histopathological and molecular profile. Most tumors share, to some extent, the same multistep carcinogenic pathways, which include a wide variety of genetic and epigenetic changes. Epigenetic alterations represent all changes in gene expression patterns that do not alter the actual DNA sequence. Recently, it has become clear that silencing of cancer related genes is not exclusively a result of genetic changes such as mutations or deletions, but it can also be regulated on epigenetic level, mostly by means of gene promoter hypermethylation. Results from recent studies have demonstrated that DNA methylation patterns contain tumor-type-specific signatures, which could serve as biomarkers for clinical outcome in the near future. The topic of this review discusses gene promoter hypermethylation in oral and oropharyngeal squamous cell carcinoma (OSCC). The main objective is to analyse the available data on gene promoter hypermethylation of the cell cycle regulatory proteinsandand to investigate their clinical significance as novel biomarkers in OSCC. Hypermethylation of both genes seems to possess predictive properties for several clinicopathological outcomes. We conclude that the methylation status ofis definitely a promising candidate biomarker for predicting clinical outcome of OSCC, especially for recurrence-free survival.
Keywords
Funding Information
- The Dutch Cancer Society (2011-4964)
This publication has 66 references indexed in Scilit:
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Endothelin Receptor Type B Gene Promoter Hypermethylation in Salivary Rinses Is Independently Associated with Risk of Oral Cavity Cancer and PremalignancyCancer Prevention Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Promoter hypermethylation in Indian primary oral squamous cell carcinomaInternational Journal of Cancer, 2010
- Methylation of p16 CpG Island Associated with Malignant Progression of Oral Epithelial Dysplasia: A Prospective Cohort StudyClinical Cancer Research, 2009
- p16 Promoter Methylation Is a Potential Predictor of Malignant Transformation in Oral Epithelial DysplasiaCancer Epidemiology, Biomarkers & Prevention, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000